Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study

Nature

Volumn 274, Issue 5673, 1978, Pages 756-761

  De The G ^a,g   Geser, A ^a   Day, N E ^a   Tukei, P M ^b,h   Williams, E M ^c   Beri, D P ^c,i   Smith, P G ^c,j   Dean, A G ^c,j   Bornkamm, G W ^a,d   Feorino, P ^e   Henle, W ^f  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b East African Virus Research Institute ^*  (Uganda)

^c Kuluva Hospital   (Uganda)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

ⁱ ICRF Cancer Epidemiology and Clinical Trials Unit ^*

^j UNIVERSITY OF HAWAII   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BURKITT LYMPHOMA; CANCER EPIDEMIOLOGY; DIAGNOSIS; EPIDEMIOLOGY; EPSTEIN BARR VIRUS; ETIOLOGY; GEOGRAPHIC DISTRIBUTION; HUMAN CELL; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; ONCOVIRINAE; RETICULOENDOTHELIAL SYSTEM; VIROLOGY; VIRUS CARCINOGENESIS;

AGE FACTORS; ANTIBODIES, VIRAL; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; COCARCINOGENESIS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALARIA; MALE; UGANDA;

EID: 0018098259     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/274756a0     Document Type: Article

References (48)

1. Epstein, M. A, Achong, B. G. and Barr, Y. M. Lancet 1, 702-703 (1964).
2. Henle, W, Diehl, V, Kohn, G, zur Hansen, H. and Henle, G. Science 157, 1064-1065 (1967).
3. Pope, J. H, Home, M. K. and Scott, M. Int. I. Cancer 3, 857-866 (1968).
4. Shope, T, Dechairo, D. and Miller, G., Proc. nam Acad. Sci. U.S.A. 70, 2487-2491 (1973)
5. Shope, T, Dechairo, D. and Miller, G., J. exp. Med. 137, 140-147 (1973).
6. Werner, J, Pinto, C. A, Haff, R. S, Henle, W. and Henle, G. J. infect Dis. 126, 678-681 (1972).
7. Henle, G. et al. J. nam Cancer Inst. 43, 1147-1157 (1969).
8. Henle, G. et al. J. nam Cancer Inst. 46, 861-871 (1971).
9. zur Hansen, H. et al., Nature 228, 1056-1058 (1970).
10. Reedman, B. M. et al. Int. J. Cancer 13, 755-763 (1974).
11. Burkitt, D. Br. J. Surg. 46, 218-223 (1958)
12. Burkitt, D. Br. J. Cancer 16, 379-386 (1962).
13. Burkitt, D., Nature 194, 232-234 (1962)
14. Burkitt, D., Br. med. J. 2, 1019-1023 (1962).
15. Booth, K, Burkitt, D. P, Bassett, D. J, Cooke, R. A. and Biddulph, J. Br. J. Cancer 21, 657-664 (1967).
16. Zieglcr, J. L, Andersson, M, Klein, G. and Henle, W. Int. I. Cancer 17, 701-706 (1976).
17. Henle, G, Henle, W and Diehl, V., Proc. nam Acad Sci. U.S.A. 58, 94-101 (1968).
18. Evans, A. S, Niederman, J. C. and McCoIlum, R. W. New Engl. J. Med. 279, 1121-1127 (1968).
19. Evans, A. S, Niederman, J. C. and McCoIlum, R. W. Proc. Planning Conference for Epidemiological Studies on Burkitt's Lymphoma and Infectious Mononucleosis, IARC Internal Technical Report Series (International Agency For Research on Cancer, Lyon, 1969).
20. Gescr, A. and de-The1, G. in Oncogenesis and Herpesviruses (ed. Biggs, P. M, de-The, G. and Payne, L. N.) 372-375, IARC Scientific Publications No. 2 (International Agency for Research on Cancer, Lyon, 1972).
21. Pike, M. C, Williams, E. H. and Wright, D. H. Br. med. I. 2, 395-399 (1967).
22. Williams, E. H, Spit, P. and Pike, M. C. Br. I. Cancer 23, 235-246 (1969).
23. Kafuko, G. W. et al. Lancet 1, 706-709 (1972).
24. Bornkamm, G. W. et al. Int. J. Cancer 17, 177-181 (1976).
25. Reedman, B. and Klein, G. Int. J. Cancer 11, 499-520 (1973).
26. de-The, G. et al. in Oncogenesis and Herpesviruses 2 (ed. de-The, G, Epstein, M. A. and zur Hausen, H.) 3-16, IARC Scientific Publications No. 11 (International Agency for Research on Cancer, Lyon, 1975).
27. 24 Henle, G. and Henle, W. J. Bact. 91, 1248-1256 (1966).
28. Henle, W. et al. Science 169, 188-190 (1970).
29. Henle, G, Henle, W. and Klein, G. Int. J. Cancer 8, 272-282 (1971).
30. Sohier, R. and de-The, G. Int. J. Cancer 9, 524-528 (1972).
31. Dye, L. A. and Feorino, P. M. Appl. Microbiol. 25, 315-316 (1973).
32. Casey, H. L. in US Public Health Monograph 74 (1964).
33. Hilgers, G, Dean, A. G. and de-The, G. J. nam Cancer Inst. 54, 49-51 (1975).
34. 31 Olding, L. B, Jensen, F. C., Sl Oldstone, B. A. J. exp. Med. 141, 561-572 (1975).
35. Joncas, J. H, Menez M. J. and Huang, E. S., Nature 258, 432-433 (1975).
36. de-The, G. and Lenoir, G. in Comparative Diagnosis of Viral Diseases (ed. Kurstak, E.) 195-240 (Academic, New York, 1977).
37. Gross, L. Oncogenic Viruses (Pergamon, New York, 1970).
38. de-The, G. Lancet 1, 335-338 (1977).
39. Dalldorf, G, Linsell, C. A, Barnhart, F. E. and Martyn, R. Perspectives BioL Med. 7, 435-449 (1964).
40. Burkitt, D. J. nam Cancer Inst. 42, 19-28 (1969).
41. O'Conor, G. T. Am. J. Med. 48, 279-285 (1970).
42. Johansson, B, Klein, G, Henle, W. and Henle, G. Int. J. Cancer 6, 450-462 (1970).
43. Williams, E. H. et al. Br. J. Cancer 37, 109-122 (1978).
44. Williams, E. H, Day, N. E. and Geser, A. G. Lancet 2, 19-22 (1974).
45. Annual Report (International Agency for Research on Cancer, Lyon, 1977)
46. Epstein, M. A. Cancer Res. 36, 711-714 (1976).
47. Higginson, J, de-The, G, Geser, A. and Day, N. Int. J. Cancer 7, 565-574 (1971).
48. de-The, G. Biomedicine 28, 15-17 (1978).